The two main drivers driving up the value of the oncolytic virus immunotherapy market are the rising incidence of cancer and the increase in healthcare expenditures.Wilmington, Delaware, United States, Feb. 21, 2024 (GLOBE NEWSWIRE) Transparency Market Research Inc. - The global oncolytic virus immunotherapy market was projected to attain US$ 110.2 million in 2022. It is anticipated to garner a 21.1% CAGR from 2023 to 2031 and by 2032, the market is likely to attain US$ 572.2 million by 2031.
Immunotherapy obviates the need for often toxic chemotherapy in sensitive populations like infants or older adults and increases the chance of cures in specific selected populations. TheHealthSite.com
Get immunotherapy for cancer latest news, Article video and Photos on immunotherapy for cancer Explore latest health updates, news, information from TheHealthSite.com